KALA BIO, Inc. (KALA)
(Delayed Data from NSDQ)
$6.51 USD
-0.07 (-1.06%)
Updated May 22, 2024 03:25 PM ET
After-Market: $6.52 +0.01 (0.15%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Brokerage Reports
0 items in cart
KALA BIO, Inc. [KALA]
Reports for Purchase
Showing records 341 - 360 ( 365 total )
Company: KALA BIO, Inc.
Industry: Unclassified
A New View on Ocular Drug Delivery; Initiating at Buy and $35 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: KALA BIO, Inc.
Industry: Unclassified
Company: KALA BIO, Inc.
Industry: Unclassified
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: KALA BIO, Inc.
Industry: Unclassified
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: KALA BIO, Inc.
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: KALA BIO, Inc.
Industry: Unclassified
Dry Eye Program Advancing on Schedule with Concurrent Review and Trial
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: KALA BIO, Inc.
Industry: Unclassified
Clarity on Dry Eye Program in Late Q2/Q3 and INVELTYS August 24 PDUFA
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: KALA BIO, Inc.
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: KALA BIO, Inc.
Industry: Unclassified
Corporate Update in Front of Important 2018 Catalysts
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: KALA BIO, Inc.
Industry: Unclassified
Company: KALA BIO, Inc.
Industry: Unclassified
Company: KALA BIO, Inc.
Industry: Unclassified
Dry Eye Potentially Approvable--Next Steps Midyear; Surgery Moves Into Review
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: KALA BIO, Inc.
Industry: Unclassified
Week Ahead
Provider: WEDBUSH SECURITIES INC.
Company: KALA BIO, Inc.
Industry: Unclassified
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: KALA BIO, Inc.
Industry: Unclassified
Down to the Wire: Preview of Two Imminent Catalysts
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: KALA BIO, Inc.
Industry: Unclassified
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: KALA BIO, Inc.
Industry: Unclassified
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: KALA BIO, Inc.
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: KALA BIO, Inc.
Industry: Unclassified
Company: KALA BIO, Inc.
Industry: Unclassified
Cash Runway into 2019 Plus Imminent Material Catalysts
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L